Guidance for market authorization requirements for COVID-19 vaccines: Rolling submissions, non-clinical and clinical requirements

Guidance for market authorization requirements for COVID-19 vaccines: Rolling submissions, non-clinical and clinical requirements This document provides guidance on the standard for accepting a rolling submission and non-clinincal requirements for authorization. 2022-07-28 Health Canada open-ouvert@tbs-sct.gc.ca Health and SafetyCOVID-19SARS-CoV-2 virusCOVID-19 vaccinesCOVID-19 drugsmarket authorization requirementsrolling submissionsnon-clinical-and-clinical requirements Guidance for market authorization requirements for COVID-19 vaccines: Rolling submissions, non-clinical and clinical requirementsHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/guidance-market-authorization-vaccines/rolling-submissions-non-clinical-requirements.html Guidance for market authorization requirements for COVID-19 vaccines: Rolling submissions, non-clinical and clinical requirementsHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/covid19-industrie/medicaments-vaccins-traitements/ligne-directrices-autorisations-mise-marche-vaccins/presentations-continu-exigences-non-cliniques.html

This document provides guidance on the standard for accepting a rolling submission and non-clinincal requirements for authorization.

Data and Resources

Similar records